Prodrug-based design, synthesis, and biological evaluation of N-benzenesulfonylpiperidine derivatives as novel, orally active factor Xa inhibitors

Parallel synthesis identified potent and selective fXa inhibitors with a benzenesulfonyl group as an S4 binding element. Masking of their hydrophilic groups led to related prodrugs with oral anticoagulant effects.